Point of Care Manufacturing: the Trojan Horse to introduce gene therapies
Another one you couldn't make up
UK Government gives the green light
Whether you know it or not, UK Government, through MHRA, now allows hospitals to manufacture at point of care, but only for advanced therapies, which include gene therapies. This is the announcement:
It claims:
“The establishment of a regulatory framework for POC manufacturing would bring a range of benefits to patients, healthcare professionals and innovators.”
“The UK will be the first country to introduce a tailored framework for the regulation of innovative products manufactured at the point where a patient receives care, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced today. This will mean that new medicines with very short shelf lives and highly personalised medicines can more easily be made in or near a hospital setting or ambulance and can get to the patients who need them much more quickly.”
It’s har…